MedPath
HSA Approval

RESINSODIO POWDER 4.95 g/5 g

SIN09521P

RESINSODIO POWDER 4.95 g/5 g

RESINSODIO POWDER 4.95 g/5 g

November 6, 1997

ZYFAS MEDICAL CO

ZYFAS MEDICAL CO

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS MEDICAL CO
Licence HolderZYFAS MEDICAL CO

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

POWDER, FOR SUSPENSION

ORAL

Medical Information

V03AE01

polystyrene sulfonate

Manufacturer Information

ZYFAS MEDICAL CO

LABORATORIOS RUBIO SA

Active Ingredients

SODIUM POLYSTYRENE SULPHONATE

4.95 g/5 g

Tolevamer

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RESINSODIO POWDER 4.95 g/5 g - HSA Approval | MedPath